Based on the investor's beginner level, long-term strategy, and available funds, Rayonier Advanced Materials Inc (RYAM) is not a strong buy at the moment. While there are some positive signals like bullish moving averages and analyst optimism, the company's financial struggles, negative free cash flow, and recent losses outweigh the potential upside. A hold is recommended until clearer signs of financial stability and profitability emerge.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), and the MACD histogram is positive at 0.185, indicating a bullish trend. However, RSI at 61.132 is neutral, and the stock is trading near resistance levels (R1: 10.681). Short-term stock trend analysis suggests limited upside potential.

Analyst upgrade from RBC Capital with a raised price target to $14, citing positive market response to the company's value-over-volume strategy.
Achieved an 18% price increase for 85% of its cellulose specialties business in 2025.
Negative free cash flow of $88 million for 2025, highlighting financial struggles.
Fourth-quarter loss of $21 million, worsening YoY.
Revenue declined by 1.17% YoY in Q4 2025, indicating challenges in growth.
High-cost debt remains a concern.
In Q4 2025, revenue dropped by 1.17% YoY to $417.5 million. Net income improved slightly but remained negative at -$21 million, up 31.86% YoY. EPS also improved to -0.31, up 29.17% YoY. Gross margin increased to 8.87%, up 1.49% YoY. Despite some improvements, the company is still facing profitability challenges.
RBC Capital raised the price target to $14 from $9 and maintained an Outperform rating, citing the company's strategic shift towards value-over-volume and repricing efforts. Analysts are optimistic about the company's direction but cautious about its financial challenges.